{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:56:39Z","timestamp":1790553399906,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["DA023085"],"award-info":[{"award-number":["DA023085"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.expneurol.2013.01.001","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T14:10:42Z","timestamp":1357740642000},"page":"359-372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity"],"prefix":"10.1016","volume":"247","author":[{"given":"Bin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Traini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Killinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Moszczynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2013.01.001_bb0005","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.nbd.2011.11.005","article-title":"Dopamine D(1) receptor deletion strongly reduces neurotoxic effects of methamphetamine","volume":"45","author":"Ares-Santos","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0010","first-page":"872","article-title":"Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease","volume":"18","author":"Azeredo da Silveira","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0015","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1523\/JNEUROSCI.1541-11.2012","article-title":"L-DOPA impairs proteasome activity in parkinsonism through D1 dopamine receptor","volume":"32","author":"Berthet","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0020","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0022-3565(25)38650-7","article-title":"Further studies of the role of hyperthermia in methamphetamine neurotoxicity","volume":"268","author":"Bowyer","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0025","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1098-2396(199710)27:2<153::AID-SYN6>3.0.CO;2-D","article-title":"Methamphetamine selectively damages dopaminergic innervation to the nucleus accumbens core while sparing the shell","volume":"27","author":"Broening","year":"1997","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2013.01.001_bb0035","doi-asserted-by":"crossref","first-page":"30057","DOI":"10.1074\/jbc.M100142200","article-title":"Oxidative modification and inactivation of the proteasome during coronary occlusion\/reperfusion","volume":"276","author":"Bulteau","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0040","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1134\/S0006297906080050","article-title":"Ubiquitin-protein ligase parkin and its role in the development of Parkinson's disease","volume":"71","author":"Buneeva","year":"2006","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.expneurol.2013.01.001_bb0045","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1002\/mds.23263","article-title":"Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders","volume":"25","author":"Callaghan","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0050","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drugalcdep.2011.06.013","article-title":"Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs","volume":"120","author":"Callaghan","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0055","first-page":"105","article-title":"Decreases in evoked overflow of dopamine in rat striatum after doses of methamphetamine","volume":"280","author":"Cass","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0060","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/hmg\/ddr618","article-title":"Sustained expression of PGC-1alpha in the rat nigrostriatal system selectively impairs dopaminergic function","volume":"21","author":"Ciron","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0169-328X(99)00286-7","article-title":"Cloning and distribution of the rat parkin mRNA","volume":"75","author":"D'Agata","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0070","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0278-5846(01)00301-3","article-title":"Distribution of parkin in the adult rat brain","volume":"26","author":"D'Agata","year":"2002","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2013.01.001_bb0075","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/hmg\/ddg044","article-title":"Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death","volume":"12","author":"Darios","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.nbd.2009.03.013","article-title":"Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease","volume":"35","author":"Dusonchet","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0085","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1471-4159.2001.00549.x","article-title":"Parallel increases in lipid and protein oxidative markers in several mouse brain regions after methamphetamine treatment","volume":"79","author":"Gluck","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0090","doi-asserted-by":"crossref","first-page":"43628","DOI":"10.1074\/jbc.M308947200","article-title":"Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons","volume":"278","author":"Goldberg","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0095","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1096\/fasebj.11.7.9212076","article-title":"Degradation of oxidized proteins in mammalian cells","volume":"11","author":"Grune","year":"1997","journal-title":"FASEB J."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0100","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.neuro.2009.02.003","article-title":"Diadenosine tetraphosphate reduces toxicity caused by high-dose methamphetamine administration","volume":"30","author":"Harvey","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2013.01.001_bb0105","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1046\/j.1471-4159.1999.0720661.x","article-title":"Differential regional effects of methamphetamine on the activities of tryptophan and tyrosine hydroxylase","volume":"72","author":"Haughey","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0110","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1097\/00001756-199911080-00025","article-title":"Identification and distribution of Parkin in rat brain","volume":"10","author":"Horowitz","year":"1999","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2013.01.001_bb0115","first-page":"257","article-title":"Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain","volume":"214","author":"Hotchkiss","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0120","doi-asserted-by":"crossref","first-page":"28572","DOI":"10.1074\/jbc.M200666200","article-title":"Effect of wild-type or mutant Parkin on oxidative damage, nitric oxide, antioxidant defenses, and the proteasome","volume":"277","author":"Hyun","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0125","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/hmg\/ddg239","article-title":"Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse","volume":"12","author":"Itier","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0130","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/hmg\/ddh180","article-title":"Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis","volume":"13","author":"Jiang","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0135","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ncomms1669","article-title":"Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells","volume":"3","author":"Jiang","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0140","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1094-148","article-title":"Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain","volume":"8","author":"Kaplitt","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1750-1326-5-47","article-title":"Parkinson-related parkin reduces alpha-Synuclein phosphorylation in a gene transfer model","volume":"5","author":"Khandelwal","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0150","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/sj.gt.3302497","article-title":"Parkinson's disease: viral vector delivery of parkin generates model results in rats","volume":"12","author":"Kirik","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/exnr.1997.6736","article-title":"Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors","volume":"150","author":"Klein","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0160","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neulet.2006.03.001","article-title":"Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model","volume":"401","author":"Klein","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0165","doi-asserted-by":"crossref","first-page":"E453","DOI":"10.1152\/ajpendo.00204.2007","article-title":"Regulation of muscle protein synthesis during sepsis and inflammation","volume":"293","author":"Lang","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0170","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1586\/14789450.4.6.769","article-title":"Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies","volume":"4","author":"Lim","year":"2007","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.expneurol.2013.01.001_bb0175","doi-asserted-by":"crossref","first-page":"17510","DOI":"10.1073\/pnas.0405313101","article-title":"Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease","volume":"101","author":"Lo Bianco","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MNH.0b013e3280117ce7","article-title":"Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling","volume":"16","author":"Mak","year":"2007","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0185","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.expneurol.2007.06.019","article-title":"rAAV-mediated nigral human parkin over-expression partially ameliorates motor deficits via enhanced dopamine neurotransmission in a rat model of Parkinson's disease","volume":"207","author":"Manfredsson","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0190","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/mt.2009.286","article-title":"Comparative transduction efficiency of AAV vector serotypes 1-6 in the substantia nigra and striatum of the primate brain","volume":"18","author":"Markakis","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0195","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/156652311795684759","article-title":"Adeno-Associated Virus (AAV) Vectors in the CNS","volume":"11","author":"McCown","year":"2011","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0200","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1042\/BST0340749","article-title":"Parkin: a multifaceted ubiquitin ligase","volume":"34","author":"Moore","year":"2006","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0205","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0028-3908(80)90010-6","article-title":"Short-term and long-term effects of methamphetamine on biogenic amine metabolism in extra-striatal dopaminergic nuclei","volume":"19","author":"Morgan","year":"1980","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2013.01.001_bb0210","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1471-4159.2010.07147.x","article-title":"Methamphetamine oxidatively damages parkin and decreases the activity of 26S proteasome in vivo","volume":"116","author":"Moszczynska","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0215","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1097\/00001756-200107030-00037","article-title":"Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain","volume":"12","author":"Nguyen","year":"2001","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2013.01.001_bb0220","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbrc.2003.08.059","article-title":"Parkin suppresses wild-type alpha-synuclein-induced toxicity in SHSY-5Y cells","volume":"309","author":"Oluwatosin-Chigbu","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0225","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/092986708783330692","article-title":"Aggresome formation and neurodegenerative diseases: therapeutic implications","volume":"15","author":"Olzmann","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0230","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/sj.mt.6300154","article-title":"DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice","volume":"15","author":"Paterna","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0235","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2202-6-71","article-title":"Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity","volume":"6","author":"Perez","year":"2005","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0240","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0896-6273(02)01125-X","article-title":"Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons","volume":"36","author":"Petrucelli","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2013.01.001_bb0245","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0006-8993(82)90198-6","article-title":"Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain","volume":"235","author":"Ricaurte","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0250","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-2999(02)01985-4","article-title":"Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine","volume":"449","author":"Riddle","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0255","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.brainres.2007.11.015","article-title":"Specific AAV serotypes stably transduce primary hippocampal and cortical cultures with high efficiency and low toxicity","volume":"1190","author":"Royo","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0260","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2990.2008.00952.x","article-title":"Review: Familial Parkinson's disease\u2013genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease","volume":"34","author":"Schiesling","year":"2008","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0265","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/77060","article-title":"Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase","volume":"25","author":"Shimura","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0270","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0896-6273(03)00084-9","article-title":"Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity","volume":"37","author":"Staropoli","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2013.01.001_bb0275","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/157015911795016985","article-title":"Enhanced Hyperthermia Induced by MDMA in Parkin Knockout Mice","volume":"9","author":"Takamatsu","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0280","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1460-9568.2007.05688.x","article-title":"Augmentation of methamphetamine-induced toxicity in the rat striatum by unpredictable stress: contribution of enhanced hyperthermia","volume":"26","author":"Tata","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0285","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.ymthe.2006.06.009","article-title":"Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease","volume":"14","author":"Vercammen","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0290","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1093\/hmg\/ddi413","article-title":"Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function","volume":"14","author":"Wang","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0295","doi-asserted-by":"crossref","first-page":"ra88","DOI":"10.1126\/scisignal.2001232","article-title":"Regulation of the 26S proteasome complex during oxidative stress","volume":"3","author":"Wang","year":"2010","journal-title":"Sci. Signal."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0300","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.yjmcc.2010.10.017","article-title":"The next step in gene delivery: molecular engineering of adeno-associated virus serotypes","volume":"50","author":"Wang","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0305","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/hum.2005.16.262","article-title":"Parkin gene therapy for alpha-synucleinopathy: a rat model of Parkinson's disease","volume":"16","author":"Yamada","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1749-6632.2009.05141.x","article-title":"Amphetamine toxicities: classical and emerging mechanisms","volume":"1187","author":"Yamamoto","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0315","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0896-6273(03)00143-0","article-title":"Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in Drosophila","volume":"37","author":"Yang","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2013.01.001_bb0320","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/00001756-200507130-00017","article-title":"Neuroprotection of Parkin against apoptosis is independent of inclusion body formation","volume":"16","author":"Yang","year":"2005","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2013.01.001_bb0325","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbrc.2011.05.116","article-title":"Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin","volume":"410","author":"Yang","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2013.01.001_bb0330","doi-asserted-by":"crossref","first-page":"13354","DOI":"10.1073\/pnas.240347797","article-title":"Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1","volume":"97","author":"Zhang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488613000149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488613000149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T16:36:12Z","timestamp":1745944572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488613000149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":66,"alternative-id":["S0014488613000149"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2013.01.001","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2013.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}